LONDON, March 28, 2018 /PRNewswire/ — Download the full report: https://www.reportbuyer.com/product/5360520 The global cardiac resynchronization therapy (CRT) market is expected to reach USD 9.2 billion by 2025, according to a new report by Grand View Research, Inc. Increasing prevalence of cardiac disorders and rising incidences of heart failure are expected to boost the CRT market […]
Coronary/Structural Heart
2018 Global Electrocardiograph (ECG) Market Report – Projected to Reach $7 Billion in 2022 from $5 Billion in 2016 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)– The “Global Electrocardiograph (ECG) Market Analysis (2017-2023)” report has been added to ResearchAndMarkets.com’s offering. Electrocardiograph (ECG) Market was valued at $5 billion in 2016, and is estimated to reach $7 billion by 2023, growing at a CAGR of 5.8% during the forecast period. Technological advancements of ECG devices such as their portability, […]
Inflammation Testing Prompts Care Changes Leading to Significantly Lower Levels in Patients with Increased Cardiovascular Risk Due to Diabetes or Pre-Diabetes
BOCA RATON, Fla., March 27, 2018 /PRNewswire/ — New research from MDVIP and Cleveland HeartLab finds that patients with diabetes, pre-diabetes or no evidence of diabetes whose physicians ordered myeloperoxidase (MPO) inflammation testing achieved sharp reductions in MPO levels over five years. The investigators theorize the levels declined over time as a result […]
Renova Therapeutics Announces Issuance of Patent Covering Delivery and Expression of Paracrine Genes
SAN DIEGO, March 27, 2018 /PRNewswire/ — Renova™ Therapeutics, a biotechnology company developing gene and peptide-based treatments for cardiovascular and metabolic diseases, announced today that the European Patent Office has issued Patent No. 2814513, “Systemic Delivery and Regulated Expression of Paracrine Genes for Cardiovascular Diseases and Other Conditions” to The Regents of the […]
Edwards Prevails In U.S. Patent Office Review That Finds Boston Scientific Transcatheter Valve Patent Claims Invalid
WASHINGTON, March 23, 2018 — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that the United States Patent and Trademark Office (USPTO) decided in Edwards’ favor in an Inter Partes Review (IPR) of Boston Scientific’s U.S. transcatheter heart valve patent, […]
North America Electrocardiograph (ECG) Market Analysis 2017-2023 – Resting ECG, Stress ECG, and Holter Monitors – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “North America Electrocardiograph (ECG) Market Analysis (2017-2023)” report has been added to ResearchAndMarkets.com’s offering. The North America Electrocardiograph (ECG) Market is expected to witness market growth of 4.9% CAGR during the forecast period (2017 – 2023). Electrocardiography (ECG) is a non-invasive medical test used in recording electrical activity of the heartbeat over […]
North America Vascular Graft Market Analysis 2017-2023 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “North America Vascular Graft Market Analysis (2017-2023)” report has been added to ResearchAndMarkets.com’s offering. The North America Vascular Graft Market is expected to witness market growth of 5.4% CAGR during the forecast period (2017 – 2023). A vascular graft is a medical device which is used as an artificial blood vessel. These […]
Global Transcatheter Aortic Valve Implantation (TAVI) Market Analysis & Outlook 2018-2022 with Profiles of Abbott Laboratories, Boston Scientific, Edwards Lifesciences & Medtronic – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Transcatheter Aortic Valve Implantation (TAVI) Market: Industry Analysis & Outlook (2018-2022)” report has been added to ResearchAndMarkets.com’s offering. “Global TAVI Market: Industry Analysis & Outlook (2018-2022)” analyses the development of this market, with focus on the U.S and European markets. The global TAVI market is expected to grow in future due […]
JenaValve Technology Appoints Keith D. Dawkins, M.D., as Board Member
IRVINE, Calif.–(BUSINESS WIRE)– JenaValve Technology, Inc., a developer, manufacturer and marketer of differentiated transcatheter aortic valve replacement (TAVR) systems for the treatment of aortic valve disease, today announced the appointment of veteran medical device executive Keith D. Dawkins, M.D., as a new JenaValve board member. “As JenaValve advances its clinical development […]
Philips provides University of Ottawa Heart Institute with innovative health technology solutions for their expanded cardiovascular care facility
AMSTERDAM, March 23, 2018 /CNW/ – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology has delivered a broad range of health technology solutions to the University of Ottawa Heart Institute (UOHI) – Canada’s largest and foremost heart health centre dedicated to understanding, treating, and preventing heart disease. Today, […]



